Highlights
- WELL Health Technologies Corp (TSX: WELL) has been trending on the stock markets after releasing its fourth-quarter and annual results for fiscal 2021 on Thursday morning, March 31.
- The company said that its 2021 revenue increased 502 per cent from 2020, mainly due to acquisitions and organic growth.
- The WELL stock galloped by nearly 10 per cent and was trading at C$ 4.92 apiece at 9:43 AM EST on Thursday following its positive earnings report.
WELL Health Technologies Corp (TSX: WELL) has been trending on the stock markets after it released its Q4 and FY results for fiscal 2021 on Thursday, March 31.
The Canadian healthcare service company operates a portfolio of healthcare clinics and also promotes digitization in the health sector through its electronic medical records business.
WELL Health, in its earnings report, said that its 2021 revenue increased by 502 per cent a year-on-year (YoY), mainly due to acquisitions and organic growth.
Let us have a detailed look at WELL Health’s performance.
WELL Health Technologies Corp (TSX: WELL) financial performance in Q4 FY 2021
The Vancouver, British Columbia-headquartered firm reported a revenue of C$ 115.7 million in the fourth quarter of fiscal 2021, representing a YoY rise of 573 per cent.
Its adjusted gross margin improved to 54.9 per cent in the latest quarter, up from 46.5 per cent a year ago.
The C$-1 billion market cap firm recorded an adjusted EBITDA of C$ 25.67 million in Q4 FY2021, as compared to 0.76 million a year ago.
WELL Health significantly improved its net profit to C$ 0.707 million in the latest quarter against a net loss of C$ 10.4 million in Q3 2021 and a gain of C$ 5.77 million earned in Q4 2020.
Also read: AQN and NPI: 2 TSX clean stocks as Canada plans to cut emissions by 40%
WELL Health’s stock performance
WELL stock galloped by nearly 10 per cent and was trading at C$ 4.92 apiece at 9:43 AM EST on Thursday following the release of its earnings report.
Bottomline
WELL Health Technologies increased its total omnichannel visits by 121 per cent YoY to 0.7 million in Q4 2021.
The company said that it expects its annual revenue to surpass 0.5 billion in 2022, underpinned by its organic growth strategies paired with tuck-in acquisitions.
Also read: Razor (RZE) and FHYD: 2 Canadian penny stocks that rose 700% in 1 year
Please note, the above content constitutes a very preliminary observation based on the industry, and is of limited scope without any in-depth fundamental valuation or technical analysis. Any interest in stocks or sectors should be thoroughly evaluated taking into consideration the associated risks.